
Oregon Compounding Centers, Inc. Sterile Products Recalled
Users or recipients of these products should immediately discontinue use and return the recalled unexpired products
San Diego, CA (PRWEB) October 17, 2014
AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on sterile products.
The US FDA announced on October 10 that certain unexpired human and veterinary sterile products by Oregon Compounding Centers, Inc. are recalled due to lack of sterility assurance.
The reason for the recall is based on a recent inspection which identified an issue with sterility assurance. In case of microbial contamination patients face the risk of serious, life-threatening, infections. The affected products were made from July 1, 2014 through September 22, 2014, and were distributed in Oregon and Washington.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “We are determined to keep an eye on FDA announcements concerning sterile products and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”
As the FDA recommends, “Users or recipients of these products should immediately discontinue use and return the recalled unexpired products.”
AttorneyOne.com has further information on sterile products at the website including the latest major drug, food, and medical products law news.
Headquartered in San Diego, CA, Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/09/prweb12252896.htm